Navigating the Preclinical Phase of Drug Development
In the complex journey of drug development, the preclinical stage is a critical juncture where promising discoveries face their first true test. It's a landscape filled with scientific, regulatory, and strategic challenges. Vivogenia was founded on a single principle: to provide the expert guidance needed to navigate the necessary studies and experiments needed to bring your idea to the clinic.
“We don't just manage studies; we become a dedicated extension of your team, providing the integrated scientific and project management expertise that small biotechs and startup pharma companies need to compete and succeed.”
Our Mission
To empower our clients to make informed, data-driven decisions throughout the preclinical development process by leveraging our scientific expertise, extensive partner network and passion for helping develop transformational therapies.
Our Approach
At Vivogenia, we believe in a partnership built on transparency, scientific rigor, and strategic foresight. Our approach is grounded in these key areas:
Integrated Strategy: We look at the entire program, not just a single study. Our strategies ensure that every experiment, from target validation, model selection, to pivotal GLP toxicology, is designed with the final regulatory submission in mind.
Scientific Excellence: Our consulting is rooted in deep scientific expertise. We work together with your scientific team to develop and propose experimental designs and controls that suit your timeline and budget.
Flexibility: Customized solutions that scale with your needs and budget.
Network: An extensive, qualified network of partner CROs to ensure the right studies are placed with the right experts.
De-risking: We plan experiments by immediately identifying experiments that would make or break your therapy.